New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
CASI Pharmaceuticals Inc. (CASIF) vs Passage Bio, Inc. (PASG)
- CASI Pharmaceuticals Inc. CASIF 0.11 +10.00%
- Passage Bio, Inc. PASG 3.92 +8.59%
CASI Pharmaceuticals Inc. and Passage Bio, Inc. are both Biotechnology companies. CASI Pharmaceuticals Inc. and Passage Bio, Inc. are of similar size ($12.4M and $11.6M). Across the 8 metrics below, Passage Bio, Inc. leads on 5 and CASI Pharmaceuticals Inc. on 3.
Valuation
Profitability
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack